CANDID THERAPEUTICS
HQ - San Diego, CA
Summary
Candid Therapeutics is focused on developing innovative T-cell engager antibodies to selectively deplete autoreactive B-cells, aiming to transform the treatment of autoimmune diseases with safer and more effective therapies.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 282 M
Avg. Deal Size£ 282 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2025 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
